Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Statistical Methods in Medical Research
|
October 6, 2025
Implementing response-adaptive randomisation in stratified rare-disease trials: Design challenges and practical solutions
Rajenki Das, Nina Deliu, Mark R Toshner, et al.
Trials
|
July 11, 2025
StratosPHere 2: statistical analysis plan for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2
Rajenki Das, Nina Deliu, Mark R Toshner, et al.
PLOS Digital Health
|
March 30, 2023
Modelling and classifying joint trajectories of self-reported mood and pain in a large cohort study
Rajenki Das, Mark Muldoon, Mark Lunt, et al.
Trials
|
October 15, 2024
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2
Nina Deliu, Rajenki Das, Angelique May, et al.
Scientific Reports
|
December 8, 2023
Diversity of symptom phenotypes in SARS-CoV-2 community infections observed in multiple large datasets
Martyn Fyles, Karina-Doris Vihta, Carole H Sudre, et al.
Infectious Disease Modelling
|
July 22, 2020
Using statistics and mathematical modelling to understand infectious disease outbreaks: COVID-19 as an example
Christopher E Overton, Helena B Stage, Shazaad Ahmad, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Statistical Methods in Medical Research
|
October 6, 2025
Implementing response-adaptive randomisation in stratified rare-disease trials: Design challenges and practical solutions
Rajenki Das, Nina Deliu, Mark R Toshner, et al.
Trials
|
July 11, 2025
StratosPHere 2: statistical analysis plan for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2
Rajenki Das, Nina Deliu, Mark R Toshner, et al.
PLOS Digital Health
|
March 30, 2023
Modelling and classifying joint trajectories of self-reported mood and pain in a large cohort study
Rajenki Das, Mark Muldoon, Mark Lunt, et al.
Trials
|
October 15, 2024
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2
Nina Deliu, Rajenki Das, Angelique May, et al.
Scientific Reports
|
December 8, 2023
Diversity of symptom phenotypes in SARS-CoV-2 community infections observed in multiple large datasets
Martyn Fyles, Karina-Doris Vihta, Carole H Sudre, et al.
Infectious Disease Modelling
|
July 22, 2020
Using statistics and mathematical modelling to understand infectious disease outbreaks: COVID-19 as an example
Christopher E Overton, Helena B Stage, Shazaad Ahmad, et al.
Page
of 1